ASB4 and cancer: It was revealed that elevated expression levels of ASB2, WSB1, BIRC5, ASB4, FBXO41, PSMB10, FBXL8, and SPSB1 are strongly correlated with poor patient outcomes, underscoring their potential as prognostic markers for cancer.